Authors
Latest:
CIME 2024: Outlining the new standard of care in geographic atrophyMary Beth Yackey, OD, and Michael Javaheri, MD, share their perspectives on the modernization of geographic atrophy identification and treatment.
Latest:
Point-of-care testing helps dry eye diagnosisDue to the COVID-19 pandemic, optometric care is experiencing a rapid shift towards medical diagnostic testing that is taken at the time and place of patient care.
Latest:
MLB, NBA team optometrist recalls Michael Jordan era, favorite storiesR Tracy Williams, OD, FAAO, reflects on his favorite stories working as a team optometrist for the Chicago Bulls and Chicago White Sox in the last 20 years.
Latest:
Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative careIn this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.
Latest:
IKA Keratoconus Symposium 2023: Sneak peek with Dr Szczotka-FlynnLoretta Szczotka-Flynn, OD, PhD, sits down to discuss the International Keratoconus Academy's first annual keratoconus symposium, which will be held April 22-23, 2023, in Scottsdale, Arizona.
Latest:
CRU 2025: What eye care providers took home that is current, relevant, and usefulCRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Latest:
5 financial ratios to watch to track your practice’s financial healthTop 5 financial metrics every physician should know how to and use them each month
Latest:
The long and short of myopia managementAs our dependence on technology progresses, we have seen tremendous impact on all aspects of our lives—including our kids’ eyes and vision.
Latest:
CIME 2025: Luke Lindsell, OD, MD, on bridging innovation and practical care in retinal diseaseLindsell discusses promising retinal therapeutics, such as at-home therapies, gene therapy, and devices like the Valeda Light Delivery System (LumiThera), which uses photobiomodulation and shows early promise in preventing geographic atrophy altogether.
Latest:
Strabismus and athletic performance with Dr. Brian LojkaWith strabismus making headlines after Stephen Nedoroscik's performance at the 2024 Olympic Games, Dr. Lojka overviews the condition and how optometrists can care for athletes with eye conditions.
Latest:
G360: Facts vs fiction in visual field testing for glaucomaAt Glaucoma 360 2025, Danica Marrelli, OD, FAAO, dove into the data on visual field testing for patients with glaucoma.
Latest:
From craniotomy to Charles Bonnet syndromeCase complexity underscores the importance of interdisciplinary communication.
Latest:
Top 9 sports vision resourcesNew technology helps eye care practitioners assist their athlete patients
Latest:
Managing low vision in an aging populationAs Baby Boomers enter the at-risk age group for vision loss, optometrists must be ready to act.
Latest:
SECO 2023: Neuro nuggets with Dr LeeAndy Lee, MD, gives highlights from his SECO special session, "Neuro nuggets."
Latest:
In-office procedures are new option for managing cataracts, glaucoma, and lesionsAs technology improves, less-invasive treatments save patients time and money.
Latest:
Identifying and treating for the appropriate red eye in pediatrics and beyondNidhi Rana, OD, discusses key highlights from her AAOpt 2022 presentation on pediatric red eye.
Latest:
What will myopia control look like in 2034?New long-term findings illuminate the future of DIMS spectacle lenses.
Latest:
Meibomian gland dysfunction: At-home treatment devicesWarm compresses are an invaluable step in the treatment of dry eye.
Latest:
Know risks and benefits of ocular steroid useOphthalmic corticosteroids optimize outcomes in patients with ocular inflammatory conditions
Latest:
AOA 2024: Early adoption and utilization of perfluorohexceloctane (Miebo) for dry eye diseaseAccording to Adam Alexander, OD, Miebo can make headway in establishing a need for precision medication when it comes to dry eye treatment.
Latest:
Transcript: First drug-eluting contact lens approved in JapanAcuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.
Latest:
Where to begin with dry eye technologyAdding laboratory testing and meibography helps patients and practices
Latest:
5 reasons optometrists have failed to embrace myopia managementSome optometrists are reluctant to incorporate myopia control into practice. With global cases on the rise, the time to act is now.
Latest:
Fact or fiction? A closer look at management optionsAt-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.
